Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Medtronic PLC, consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Apr 24, 2026	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021
Current debt obligations	1,788)	2,874)	1,092)	20)	3,742)	11)
Accounts payable	2,644)	2,449)	2,410)	2,662)	2,276)	2,106)
Accrued compensation	2,678)	2,514)	2,375)	1,949)	2,121)	2,482)
Accrued income taxes	914)	1,358)	1,330)	840)	704)	435)
Other accrued expenses	3,634)	3,684)	3,582)	3,580)	3,551)	3,475)
Current liabilities	11,658)	12,879)	10,789)	9,051)	12,394)	8,509)
Long-term debt	26,173)	25,642)	23,932)	24,344)	20,372)	26,378)
Accrued compensation and retirement benefits	1,193)	1,158)	1,101)	1,093)	1,113)	1,557)
Accrued income taxes	1,515)	1,574)	1,859)	2,360)	2,087)	2,251)
Deferred tax liabilities	362)	403)	515)	708)	884)	1,028)
Other liabilities	2,055)	1,768)	1,365)	1,727)	1,410)	1,758)
Noncurrent liabilities	31,298)	30,545)	28,772)	30,232)	25,866)	32,972)
Total liabilities	42,956)	43,424)	39,561)	39,283)	38,260)	41,481)
Ordinary shares, par value $0.0001	—)	—)	—)	—)	—)	—)
Additional paid-in capital	20,926)	20,833)	23,129)	24,590)	24,566)	26,319)
Retained earnings	32,638)	31,475)	30,403)	30,392)	30,250)	28,594)
Accumulated other comprehensive loss	(4,101)	(4,284)	(3,318)	(3,499)	(2,265)	(3,485)
Shareholders’ equity	49,463)	48,024)	50,214)	51,483)	52,551)	51,428)
Noncontrolling interests	609)	232)	206)	182)	171)	174)
Total equity	50,072)	48,256)	50,420)	51,665)	52,722)	51,602)
Total liabilities and equity	93,028)	91,680)	89,981)	90,948)	90,982)	93,083)

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30).

The financial position over the observed period reflects a stable overall capitalization, with total liabilities and equity fluctuating within a narrow range between 89.9 billion and 93.1 billion US dollars. While total liabilities have experienced a slight net increase, total equity has seen a gradual decline, indicating a minor shift in the company's capital structure toward higher leverage.

Current Liabilities and Short-Term Obligations: Current liabilities exhibit significant volatility, primarily driven by fluctuations in current debt obligations. These obligations ranged from a low of 11 million US dollars in 2021 to a peak of 3.7 billion US dollars in 2022, followed by subsequent peaks in 2025. This pattern suggests an opportunistic use of short-term financing. Accounts payable have trended upward from 2.1 billion US dollars in 2021 to 2.6 billion US dollars by 2026, indicating an increase in trade credit utilization.
Noncurrent Liabilities and Long-Term Debt: Long-term debt remains the primary component of noncurrent liabilities, maintaining a substantial balance between 20.3 billion and 26.4 billion US dollars. A notable decrease occurred in 2022, followed by a steady recovery toward 26.2 billion US dollars by 2026. Conversely, deferred tax liabilities show a consistent downward trend, decreasing from 1.0 billion US dollars in 2021 to 362 million US dollars in 2026.
Equity Structure and Retained Earnings: A divergence is observed between retained earnings and additional paid-in capital. Retained earnings grew steadily from 28.6 billion US dollars in 2021 to 32.6 billion US dollars in 2026, reflecting consistent profit accumulation. However, additional paid-in capital declined from 26.3 billion US dollars to 20.9 billion US dollars over the same period, suggesting a systematic reduction in contributed capital, potentially through share repurchase programs.
Comprehensive Loss and Minority Interests: Accumulated other comprehensive loss has widened, moving from negative 3.5 billion US dollars in 2021 to negative 4.1 billion US dollars in 2026, with a peak loss of 4.3 billion US dollars in 2025. Additionally, noncontrolling interests remained relatively stable until 2026, where a significant increase to 609 million US dollars was recorded.

The overall solvency profile is characterized by a heavy reliance on long-term debt and a balancing act between internal growth (retained earnings) and the reduction of shareholder capital. The stability of the total liabilities and equity suggests a managed approach to growth and capital allocation despite the volatility in short-term debt instruments.

AI Ask an analyst for more

Download chart

Medtronic PLC (NYSE:MDT)

Balance Sheet: Liabilities and Stockholders’ Equity